Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 3

Investigation the effect of ramelteon on urinary bladder smoth muscle contraction-relaxation mechanism

Pages
183–186
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This effect should be taken into account in clinical use.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: A melatonin receptor agonist ramelteon is a drug that is also used in urinary tract infections.
📊
Key Findings & Data:Material and Methods: Wistar-albino (n = 8) intact female rats were used in the study.
💡
Conclusion & Impact:This effect should be taken into account in clinical use.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: A melatonin receptor agonist ramelteon is a drug that is also used in urinary tract infections. Melatonin is known to have an effect on smooth muscle contraction. In this study, we aimed to question whether ramelteon exerts a melatonin-like effect on bladder contractions. Material and Methods: Wistar-albino (n = 8) intact female rats were used in the study. After decapitation, 1.5x5 mm bladder strips were examined in an isolated organ bath in which there was Krebs-Henseleit solution. After the regulation period, ramelteon was applied non-cumulatively in two separate doses of 0.2μM, 1μM. The area under the curve (AUC) and peak to peak (p-p) values before and after the application were normalized as % change. Results: Exposure of bladder strips to ramelteon significantly increased contractions. Ramelteon caused a statistically significant increase in p-p, AUC values of spontaneous bladder contractions at a dose of 0.2 and 1μM (p < 0.05). Conclusion: Ramelteon has an activator effect on spontaneous bladder contractions unlike melatonin. The physiopathological mechanisms under activator activity need to be investigated with further studies. This effect should be taken into account in clinical use.

🔖

Cite This Article

ERCAN, Z., HEKİM, M. G., ZORLU, G., BULMUŞ, O., YAŞAR, A., SERHATLIOĞLU, I., KAÇAR, E. (2022). Investigation the effect of ramelteon on urinary bladder smoth muscle contraction-relaxation mechanism. Annals of Medical Research, Cilt: 29 - Sayı: 3, 183–186. https://ajindex.com/articles/445580

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Karim A, Tolbert D, Cao C. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. The Journal of Clinical Pharmacology. 2006;46(2):140-8
  2. Greenblatt DJ, Harmatz JS, Karim A. Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. The Journal of Clinical Pharmacology. 2007;47(4):485-96
  3. Borja NL, Daniel KL. Ramelteon for the treatment of insomnia. Clinical therapeutics. 2006;28(10):1540-55
  4. Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 2005;48(2):301-10
  5. McGechan A, Wellington K. Ramelteon. CNS drugs. 2005;19(12):1057-65
  6. Ayar A, Kutlu S, Yilmaz B, Kelestimur H. Melatonin inhibits spontaneous and oxytocin-induced contractions of rat myometrium in vitro. Neuroendocrinology Letters. 2001;22(3):199-. Harlow HJ, Weekley BL. Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. Journal of pineal research. 1986;3(3):277-84
  7. Matsuta Y, Yusup A, Tanase K, Ishida H, Akino H, Yokoyama O. Melatonin increases bladder capacity via GABAergic system and decreases urine volume in rats. The Journal of urology. 2010;184(1):386-91
  8. Semerciöz A, Onur R, Ayar A, Orhan I. The inhibitory role of melatonin on isolated guinea-pig urinary bladder: an endogenous hormone effect. BJU international. 2004;94(9):1373-6
  9. Shimizu N, Sugimoto K, Nozawa M, Kobayashi Y, Yamamoto Y, Minami T, et al. Efficacy of Ramelteon in Patients with Insomnia and Nocturia. Lower urinary tract symptoms. 2013;5(2):69-74
  10. Shimizu N, Sugimoto K, Nozawa M, Kobayashi Y, Yamamoto Y, Minami T, et al. Efficacy of ramelteon in patients with insomnia and nocturia. LUTS: Lower Urinary Tract Symptoms. 2013;5(2):69-74
  11. Zammit G, Wang-Weigand S, Rosenthal M, Peng X. Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. Journal of Clinical Sleep Medicine. 2009;5(1):34-40
  12. Rauchenzauner M, Ernst F, Hintringer F, Ulmer H, Ebenbichler CF, Kasseroler MT, et al. Arrhythmias and increased neuro-endocrine stress response during physicians’ night shifts: a randomized cross-over trial. European heart journal. 2009;30(21):2606-13
  13. Shimizu N, Nagai Y, Yamamoto Y, Minami T, Hayashi